US$ 23.85
bpc-157 ulcerative colitis phase ii Frontiers Stable Gastric Pentadecapeptide BPC 157
Description
Hematocrit elevation above 54 percent indicates polycythemia risk (affecting up to 20 percent of TRT patients), requiring therapeutic phlebotomy or dose reduction

doi:10.1001/archinternmed.2008.574

Learn more

They follow strict rules and deliver safe, tested products every time
